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Abstract
Background: Thrombelastography is a useful tool in assessment of hemostasis. Beside the traditional variables, the
velocity curve and the variable delta have lately earned attention. The velocity curve provides knowledge about the
speed of clot formation including information about thrombin generation. Delta, which only reflects enzymatic
coagulation, allows the determination of the origin of hypercoagulability when compared to clot rigidity, a variable
that reflects both platelet and enzymatic activity. The aim was to establish preliminary reference intervals for feline
thrombelastography including the velocity curve variables and delta obtained after 60 min of storage including the
assessment of coefficients of variation. Furthermore, the effect of citrate storage time (30 versus 60 min) on feline
thrombelastography will be determined.
Results: Prolonged storage times significantly reduced reaction (R) (P = 0.019) and clotting (K) (P = 0.008) times, split point
(SP) (P = 0.019) and time to maximum rate of thrombus generation (TMRTG) (P = 0.023) values whereas maximum rate of
thrombus generation (MRTG) significantly increased (P = 0.040). Preliminary reference intervals: R (min): 2.7–18.1; K (min): 0.
8–3.9; alpha (°): 27.6–75.2; maximum amplitude (mm): 18.5–62.5; clot rigidity (dyn/cm2): 1.2–8.2; coagulation index: −4.6 –
2.6; SP (min): 2.4–15.4; delta (min): 0.3–3.1; thrombus generation (mm/min): 255.3–751.2; MRTG (mm/min): 4.0–19.3; TMRTG
(min): 3.5–22.0; maximum rate of lysis (mm/min): 0.0–4.7 and time to maximum rate of lysis (min): 0.4–55.8.
Conclusion: Storage for 60 versus 30 min induces hypercoagulable tracings including the velocity curve, some of which
variables (MRTG, TMRTG) might function as sensitive markers for changes in the coagulation activity. Because of the
impact of citrate storage time on thrombelastography, reference intervals have to be established using a specific and
constant storage time in each laboratory.
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Background
Thrombelastography (TEG) is a global coagulation test
that enables assessment of hemostatic function in whole
blood combining plasma and cellular components of
hemostasis [1–3]. Recently, the global integrity of the
complex process of blood coagulation is preferably
assessed by measurement of thrombin generation [4],
which can be evaluated using the TEG velocity curve (VC)
[4] thus gaining new attention in human and veterinary
medicine. The VC is generated from the mathematical
first derivative of TEG values and dynamically reflects the
velocity of clot formation (positive curve above the
horizontal axis) and clot dissolution (negative curve below
the horizontal axis) [5, 6] as illustrated in Fig. 1. Variables
generated from the curve of clot formation include the
maximum rate of thrombus generation (MRTG) repre-
sented by the peak of this curve [5]. In human medicine,
MRTG has been shown to increase exponentially com-
pared with the non-exponential and thus less pronounced
increase of TEG alpha as a traditional marker of clot
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formation, thus allowing a more precise evaluation of clot
kinetics [7]. Other variables reflecting clot formation
derived from the velocity curve include the time to
maximum rate of thrombus generation (TMRTG), defined
as the distance on the x-axis from zero to the peak of the
curve, and the thrombus generation (TG), which is
calculated from the area under the curve and represents
an indirect measurement of clot strength [5]. TMRTG is
also believed to be a good marker of thrombin generation
in humans and shows a linear correlation with the TEG
parameter delta [6]. Delta is easily obtained from the TEG
tracing by calculating the difference between two parame-
ters R and SP of the traditional TEG curve [6] as shown in
Fig. 2. Delta represents the greatest clot growth depending
on peak thrombin generation, thus allowing the assess-
ment of thrombin generation [6]. In people, the variable
TG has been shown to correlate with thrombin-
antithrombin complex values which serve as a marker of
thrombin generation [4]. Values that can be obtained from
the curve below the horizontal axis reflect fibrinolysis and
include the maximum rate of lysis (MRL) represented by
the negative peak of this curve and the time to max-
imum rate of lysis (TMRL), which is the represented
on the x-axis from the start of the fibrinolysis curve
to its negative peak [5].
The TEG software provides two modes of calculating
the VC variables: first, VC variables can be calculated on
the basis of the maximum amplitude (MA), a traditional
TEG variable. Second, VC variables can be derived from
the clot rigidity (G), which itself is calculated from MA
and represents the global coagulation activity. Like MA, G
is dependent on factor XIII activity, concentration of
fibrinogen and thrombin, the platelet count and function,
and hematocrit [8].
Both versions (MA and G version) of calculation result
in slightly different curves and subsequently different
results. Furthermore, the variable names differ: G version
variables have a “G” appended to the end of the name, i.e.
MRTGG instead of MRTG [9].
Fig. 1 Feline thrombelastography (TEG) showing the conventional tracing (black line) with superimposed velocity curve (gray solid curve). The
gray curve above the horizontal axis reflects thrombus generation while the gray curve below represents fibrinolysis. Measurements that can be
estimated include TMRTG (time to maximum rate of thrombus generation; min), MRTG (maximum rate of thrombus generation; mm/min), TG
(thrombus generation; mm/min) from the area under the curve (AUC), TMRL (time to maximum rate of lysis; mm/min) and MRL (maximum rate
of lysis; min)
Fig. 2 Schematic representation of the variable delta (D; min; black
arrow), which can be calculated from the difference between the
reaction time (R; min; dotted arrow), i.e., the time from initiation of
coagulation until the amplitude of the conventional TEG tracing
reaches 2 mm and the split point (SP; min; longer black arrow), i.e.,
the time from starting the coagulation process until divergence of
the TEG tracings from the zero line. The delta value = R - SP
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From the clinical point of view, the TEG gained special
interest for the evaluation of hypercoagulability [10],
whereby it has an exceptional ability to detect individuals
affected by or at risk for a thromboembolic event [10, 11].
In human medicine, hypercoagulable states measured by
rapid thrombelastography have already been shown to be
a good predictor of thromboembolic events [12]. To help
differentiating the contribution of enzymatic activity
(reflecting secondary hemostasis) and platelet reactivity
(reflecting primary hemostasis) in hypercoagulable states,
the novel variable delta which represents the enzymatic
activity has been introduced [6]. In correlation with the
variable G (reflecting both primary and secondary
hemostasis), hypercoagulable states can be classified as
predominantly caused by platelet hypercoagulability if the
patients show a hypercoagulable G value and a normal
delta [6]. Neither delta nor the VC variables have yet been
evaluated in cats.
For interpretation of TEG results, pre-analytical factors
such as the sample material and the time between sam-
pling and TEG analysis have to be taken into account.
Originally designed to be run with fresh whole blood [3,
13], TEG analysis in veterinary medicine is mostly done
using re-calcified citrated whole blood [10, 14]. Because
citrate does not entirely prevent thrombin generation
since the generation of factor XIIa (via contact activation)
is not dependent on calcium, contact activation is not
inhibited in citrated samples and continues during storage,
resulting in a certain degree of thrombin generation [8,
13]. Consequently, the citrate storage time has an impact
on TEG results [13], as demonstrated previously for
people, dogs and horses [3, 15–18]. The impact of citrate
storage time on feline TEG is largely unknown. Even if a
storage time of 30 min has been recommended [13] and
has mostly been used in previous investigations in cats
[19–24], a storage time of 60 min might be preferable in
some clinical settings especially if samples are used for a
variety of different coagulation tests.
Thus, one aim of this study was to establish prelimin-
ary reference intervals (RIs) including assessment of
coefficients of variation (CVs) for traditional and novel
feline TEG parameters using 60 min incubation. The
second aim was to determine the effect of citrate storage
time (30 versus 60 min) on TEG results which, to our
knowledge, has not yet been done before in cats.
Methods
Study design
This prospective study was performed September 2015 and
ethical approval has been given by the State Agency for
Nature, Environment and Consumer Protection of North
Rhine-Westphalia (LANUV NRW, reference number:
84–02.05.20.13.090, internal number: 200a176/232). Blood
samples were collected from 21 clinically healthy adult
domestic shorthair cats from Bayer Animal Health GmbH
(Leverkusen, Germany) including 12 female and 9 male
cats with a mean age of 12.3 months (range 12–13 months).
The cats have been obtained from one breeder (Liberty
Research, Waverly, US) and were kept under defined
housing conditions in groups according to their
gender. A commercially available food was fed (Josera
Léger, Adult light, Kleinheubach, Germany) and water
was available ad libitum.
Initial health status of the cats was determined through
a routine physical examination. The blood was collected
from the cephalic vein using a 21G needle (0.8 × 16.0 mm,
Neolus needle, Terumo, Eschborn, Germany) and dropped
into two 1.4-ml 3.2% sodium citrate tubes (S-Monovette®,
1.4-ml, 9NC, Sarstedt, Wedel, Germany) which were
properly filled ensuring an ratio of blood to anticoagulant
of 9:1. In a randomized order, one tube of citrated whole
blood was used for TEG analysis. From the other tube,
citrated plasma for a routine coagulation profile including
thrombin time (TT), prothrombin time (PT), activated
partial thromboplastin time (aPTT), fibrinogen concentra-
tion and D-Dimers was obtained within 20 min after
sampling by centrifugation (Eppendorf 58 10 R, Eppendorf
AG, Hamburg, Germany) for 10 min. The plasma was
then transferred into plain tubes (Eppendorf Safe-Lock
Tubes, Eppendorf AG, Hamburg, Germany) and frozen at
−80 °C. For coagulation analyses, frozen samples were
shipped on dry ice to the department of Veterinary
Clinical Sciences, Clinical Pathophysiology and Clinical
Pathology (Justus-Liebig University, Giessen, Germany),
and stored at −80 °C until measurements were performed
as batch on the automated coagulation analyzer STA
Compact ® (Stago Germany, Düsseldorf, Germany) within
a year after sample collection as described previously for
dogs [25].
One week prior to the study, a complete blood count
(CBC) measured with the automated hematology analyzer
ADVIA® 120 Hematology System (Siemens HealthCare
GmbH, Erlangen, Germany; software version: no. 1) which
has been evaluated previously for cats [26] and a biochem-
istry profile (IDEXX Catalyst Dx®, IDEXX GmbH,
Ludwigsburg, Germany) were performed. Results were
compared with RIs provided by the manufacturer of the
clinical chemistry analyzer. Cats were included in our
study when they were considered healthy based on
the physical examination and the absence of clinically
relevant abnormalities of the hematological and blood
chemical examination.
The hematocrit and platelet count were reevaluated
from citrated blood at the day of blood sampling for
TEG analysis. Results were corrected by the factor 1.1 to
take the dilution of the sample with citrate into consid-
eration. The hematocrit value was evaluated with the
microhematocrit method after centrifugation of 5 min at
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31,689 G using a microhematocrit-centrifuge (“Haema-
tokrit 24”, Hettich, Tuttlingen, Germany). The platelet
count was estimated semiquantitatively by counting
platelets in the monolayer of a May-Grünwald-Giemsa
stained blood smear, whereby the mean of 10 high
power fields (100× objective) was calculated and multi-
plied by a factor of 20 as previously recommended [27]
to obtain the approximate platelet count (×103/μl).
Thrombocytopenia was defined as values below 200
(×103/μl) [26]. When moderate to marked platelet
clumping was seen, the assessed count was judged falsely
low. Moderate to marked platelet clumping was defined
as a high number of platelets within clumps that did not
allow accurate counting of individual platelets [27]. As
an addition to the size of clumps, the number of clumps
was used to further classify the platelet clumping as low,
moderate or high grade clumping. According to this
classification, 13 cats were categorized as having low
grade, 2 cats as moderate and 5 cats as having high
grade platelet clumping.
TEG analysis
The analyses were always performed by the same person
(CE) using three computerized TEG 5000 analyzers
(Thrombelastograph, Haemonetics Corporation, Brain-
tree, MA, USA). TEG analyses were done with recalcified
whole blood stored at room temperature and according to
the manufacturer recommendations. Briefly, standard
TEG cups (Haemoscope Corporation) were placed in the
37 °C prewarmed instrument holder and filled with 20 μl
of 0.2 M calcium chloride. After specific storage times of
either 30 and/or 60 min respectively, 340 μl citrated whole
blood was added and analysis was started. Each TEG
analysis was performed for approximately 60 min and an
electric internal quality control (e-test) was performed at
least three times a day.
Blood from the first 10/21 cats was stored for 60 min
before TEG analysis, which was run in duplicates using
blood from the same tube to assess the variance. TEG
assays for the remaining 11/21 cats were performed with
blood taken from the same tubes after 30 and 60 min of
storage time respectively to assess sample stability. One
of these 11 cats had to be excluded from the study since
TEG analysis only showed flat lines.
Evaluated TEG variables include the traditional variables:
reaction time (R), clotting time (K), alpha, maximum ampli-
tude (MA), clot rigidity (G), coagulation index (CI) and clot
lysis at 30 min after MA is reached (LY30) as well as the
novel measurements: SP, delta and the values from the
velocity curve (TG, MRTG and TMRTG reflecting throm-
bin generation and MRL and TMRL reflecting clot lysis).
The VC parameters used for all statistical analyses and fig-
ures were obtained from the MA version of calculation. For
the sake of better comparison with other studies and
potential future use by other investigators, reference inter-
vals of VC parameters will be provided for both the G and
MA version of calculation.
Statistical analysis
Preliminary RIs were established for a citrate storage
time of 60 min. If samples were measured in dupli-
cates (as done for assessment of variance), the first
result was used. Data distribution regarding normality
was assessed by reviewing the histogram and the QQ
plot as well as using the Anderson-Darling test or a
symmetry test for Robust provided by the software
(Reference Value Advisor 2.1 [28]). For all variables
except for TG and TMRL, a robust method after
Box-Cox transformation (Reference Value Advisor 2.1
[28]) was used. For TG, the RI was calculated with a
parametric method after Box-Cox transformation and
RI for TMRL was established by use of a parametric
method of untransformed data respectively. Mean,
median, minimum and maximum values as well as
standard deviation was determined from untrans-
formed data. Pooled variance was used to assess the
percentage of total variation that occurred between
the duplicates.
For all statistical comparisons, a Shapiro-Wilk test was
done in advance to evaluate the assumption of normality.
The impact of citrate storage times was assessed using a
paired t-test for alpha, G, CI, TG, MRTG and TMRTG
and a Wilcoxon test for R, K, MA, LY30, SP, delta, TMRL,
MRL respectively. Because of the low number of cats in
the group of high grade clumping the assessment of
normality is limited so the influence of platelet clumps on
the results was assessed by a nonparametric test (Mann-
Whitney U test) for all variables. For all analyses, a p-value
<0.05 was considered significant.
Results
Hematological analyses
The platelet count (PLT) estimated from the blood
smear showed a thrombocytopenia (36–124 × 103/μl)
in five cats, four of which (PLT: 44–124 × 103/μl)
had marked aggregation on the blood smear so the
count was considered falsely low. The remaining cat
showing a thrombocytopenia (36 × 103/μl) only had a
moderate degree of platelet clumping. This cat did
not show a thrombocytopenia on the CBC 1 week
earlier and was clinically healthy without a history of
bleeding so it was still included in the study.
Re-evaluation of the corrected hematocrit on day of
sampling demonstrated no major abnormalities.
Analyses of plasmatic hemostasis
Mean, median, range and standard deviation for TT, PT,
aPTT, fibrinogen and D-dimers are shown in Table 1.
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Compared to the laboratory internal RIs which are also
listed in Table 1, all values were considered normal de-
noting a physiological secondary hemostasis in all cats.
Preliminary RIs
One cat (1/21) had to be excluded because no TEG tracing
could be obtained. This cat showed a marked aggregation
of platelets on the blood smear and an estimated PLT count
of 44 × 103/μl. The routine coagulation parameters were
unremarkable in this cat.
Preliminary RIs, CVs as well as the mean, median, the
standard deviation, minimum and maximum for the in-
vestigated TEG variables of citrated whole blood samples
stored for 60 min are shown in Table 2.
Histograms of the distribution of all evaluated variables
after Box Cox transformation (LY30) or untransformed
data (all but LY30) are shown in Figs. 3 and 4. In one cat
(1/20), the CI and K value were not reported by the TEG
software and in another cat (1/20) no results for MRL and
TMRL were obtained. For LY30, data distribution did not
allow the calculation of a reliable RI.
The CV was <20% for the variables R, K, alpha, MA,
G, SP, TG and MRTG. For the other evaluated variables
(CI, LY30, delta, TMRTG, MRL and TMRL) CVs were
ranging between 23.6% (delta) and 83.6% (CI) respect-
ively. Statistical analysis did not reveal a significant
difference between the first and the second measure-
ment performed after a citrate storage time of 60 min
for all assessed variables.
Impact of citrate storage time
As seen in Figs. 5 and 6, citrate storage time had a
significant impact on many traditional and novel TEG
variables. When evaluating the traditional TEG variables
(Fig. 5), prolonged citrate storage time (60 versus
30 min) induced a significant decrease in median values
of R (7 min. vs. 12.8 min., P = 0.019) and K (2.5 min. vs.
3.4 min., P = 0.008) respectively. Interestingly, a marked
increase in inter-individual variation of LY30 was noted
with increasing citrate storage time. Regarding the novel
variables (Fig. 6), the TMRTG was significantly shorter
(8.92 min. vs. 15.17 min., P = 0.023), the MRTG was
significantly larger (8.03 mm/min vs. 6.26 mm/min, P =
0.04) and the SP was significantly smaller (5.9 min. vs.
11.4 min., P = 0.019) after 60 min when compared to re-
sults after 30 min of storage. Overall, these results reflect
























































Minimum 2.8 1 26.1 18.2 1.1 −4.6 2.4 2.4 0.3 244.87 3.48 3.67 0.13 9.58
Maximum 18.7 3.6 74.9 61.4 8 2.5 15.8 15.8 2.9 735.09 19.28 22.5 4.37 56.08
Mean 7.6 2.3 57.6 46.3 4.6 −0.2 11.1 6.6 1.0 563.1 9.4 9.8 1.8 28.1
Median 6.6 2.3 58.1 47.3 4.5 0.1 6.6 5.8 0.9 588.5 8.5 8.8 1.8 22.4
SD 3.8 0.7 10.7 10.0 1.7 1.6 11.6 3.2 0.6 112.9 3.5 4.5 1.1 12.8
CV(%) 15.2 4.7 13.2 8.4 19.5 83.6 57.2 15.3 23.6 8.9 11.5 27.1 33.9 35.7
Abbreviations: RI reference interval, min minutes, SD standard deviation, CV coefficient of variation, R reaction time, K clotting time, MA maximum amplitude, G clot
rigidity, CI coagulation index, LY30 clot lysis at 30 min, SP split point, TG total thrombin generation, MRTG maximum rate of thrombus generation, TMRTG time to
maximum rate of thrombus generation, MRL maximum rate of lysis, TMRL time to maximum rate of lysis
aVelocity curve variables (TG, MRTG, TMRTG, MRL, TMRL) were obtained as MA version
bReference intervals are not considered valid according to the ASVCP (American Society of Veterinary Clinical Pathology) guidelines as number of animals <20
cA valid reference interval could not be calculated with any statistical method
Table 1 Results of the traditional coagulation profile obtained from 21 cats
Variable TT (sec) PT (sec) aPTT (sec) Fibrinogen (g/l) D-dimers (μg/ml)
Mean 15.37 10.8 11.92 1.46 0.18
Median 15.4 10.8 12 1.48 0.2
Range 14–16.9 10.1–12.8 10.8–13 1.04–1.7 0.09–0.26
SD 0.82 0.56 0.74 0.17 0.05
RI (laboratory-internala) 13.4–19.1 9.9–12.2 10.8–14.0 0.6–2.2 0.0–0.3
Abbreviations: SD standard deviation, RI reference interval, TT thrombin time, PT prothrombin time, aPTT activated partial thromboplastin time, sec seconds
aFor interpretation of the values, laboratory-internal reference intervals (RIs) established from 40 clinically healthy domestic shorthair cats using a robust method
of untransformed data are additionally listed
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the development of a more hypercoagulable TEG tracing
with increasing citrate storage time. For the variables of
clot lysis, only MRL was significantly influenced by cit-
rate storage time with values being higher at 60 min
compared to 30 min (1.71 mm/min vs. 1.25 mm/min, P
= 0.049). In contrast, there was no significant impact of
citrate storage time on the other investigated TEG vari-
ables (alpha, MA, G, CI, delta, LY30, TG, TMRL).
Examples of two TEG tracings performed in a cat after
a citrate storage time of 30 and 60 min respectively is
depicted in Fig. 7 clearly demonstrating the decrease in
R, K, SP and TMRTG as well as an increase in MRTG.
Impact of platelet clumping
No statistically significant differences could be found be-
tween the group of cats classified as having low grade
clumping and those cats classified as showing high grade
platelet clumping. Table 3 provides the range and me-
dian of the different groups as well as the p-value be-
tween these two groups.
Discussion
To the authors’ knowledge, this is the first study evaluat-
ing novel TEG variables such as SP, delta and the VC
variables for cats as well as the impact of storage time
on feline TEG tracings.
There is no definite evidence why one cat (excluded
from the study) only showed flat lines drawing the con-
clusion that no clot could be detected by the analyzer.
Because the routine plasmatic coagulation parameters
were unremarkable in this cat, a coagulation disorder
seems unlikely. Relating to the TEG being a test of glo-
bal hemostasis, a platelet origin might be the reason of
undetectable clots in this cat. In fact, this cat showed
marked aggregation of platelets on the blood smear, but
since five different cats also showed moderate to marked
platelet aggregation on the blood smear and TEG trac-
ings could still be obtained, an aggregation of platelet
might not be the only reason. Further studies should be
obtained to verify this observation.
Our study demonstrated a significant impact of citrate
storage time on several traditional and novel TEG
variables. Consequently, RI’s are also influenced by the
citrate storage time and thus should be established for
any citrate storage time intended to be used in the
laboratory. However, when using the RI, the relatively
high CVs of many TEG variables have to be taken into
account.
One limitation of our study is the small number of
cats included so that potential significant effects might
have been missed. Moreover, the establishment of RIs is
hampered by the small sample size and RIs determined
here have to be considered as preliminary values. As
recommended by the American Society of Veterinary
Clinical Pathology (ASVCP) guidelines for reference
samples 20 ≤ x < 40, a robust method was mostly used
for the establishment [29]. Furthermore, these guidelines
suggest that reference intervals should not be obtained
when less than 20 samples are available [29] as was the
case for K, CI, MRL and TMRL. For reference
samples 10 ≤ x < 20, the ASVCP guidelines recom-
mend to report histograms (Figs. 3 and 4) as well as
Table 3 Comparison of the TEG results of different groups of cats categorized by the grade of platelet clumping
Group of cats Low grade of clumping High grade of clumping p-
valueVariable (unit) Number of cats Range Median Number of cats Range Median
R (sec) 13 3.3–18.7 6.5 5 5.8–9.6 8.1 0.29
K (sec) 12 1.4–3.4 2.4 5 1.7–3.4 2.3 0.67
Alpha (°) 13 26.1–70 57.8 5 49.3–66.4 58.3 0.94
MA (mm) 13 18.2–61.4 46.6 5 42.1–60.9 52.6 0.12
G (dyn/cm2) 13 1.1–8 4.4 5 3.6–7.8 5.5 0.11
LY30 (%) 13 0–36.8 5.3 5 1.2–27.6 7.9 0.92
CI (unitless) 12 −2.3 – 2.5 −0.2 5 −1.5 – 2.1 0.3 0.34
SP (min) 13 3–15.8 5.7 5 5.2–8.6 7 0.25
Delta (min) 13 0.3–2.9 0.8 5 0.6–1.1 1 0.52
TMRTG (min) 13 4.7–22.5 8.8 5 7.1–11.9 10.3 0.62
MRTG (mm/min) 13 3.5–14.7 8.1 5 6.2–12.2 9.6 0.63
TG (mm/min) 13 244.9–735.1 565 5 517.5–734.3 636.3 0.12
TMRL (min) 12 15.7–56.1 21.2 5 22.3–46.3 34.1 0.08
MRL (mm/min) 12 0.1–4.4 1.8 5 0.3–2.5 1.4 0.59
Abbreviations: SD standard deviation, R reaction time, K clotting time, MA maximum amplitude, G clot rigidity, CI coagulation index, LY30 clot lysis at 30 min, SP
split point, TG total thrombin generation, MRTG maximum rate of thrombus generation, TMRTG time to maximum rate of thrombus generation, MRL maximum
rate of lysis, TMRL time to maximum rate of lysis
Engelen et al. BMC Veterinary Research  (2017) 13:366 Page 6 of 13
mean and median values (Table 2) to help facilitate
interpretation of the values.
A direct comparison of RIs obtained in this study using
a storage time of 60 min to the results of other studies
cannot be made without serious limitations since other
studies used a different citrate storage time (i.e., 30 min)
[19, 21] or different modes of activation [19, 21] which
also can affect TEG variables. With regard to the velocity
variables, no other study evaluating the VC in feline
thrombelastography was found. For better comparability,
Table 4 provides the RIs of both the MA version and G
version of the velocity curve variables, which are slightly
different since the curves (MA version and G version) are
minimally different.
Regarding the stability of citrated whole blood, our
study shows that longer storage times induce a more
hypercoagulable TEG tracing which is not only
represented by a shorter R, K and SP but also can be
Fig. 3 Histograms showing distribution of untransformed (all but LY30) data obtained for calculation of the reference interval of the traditional
TEG. Data for measurement included the first results of all samples after 60 min of storage time. The solid grey line represents the upper and the
lower limit of the reference interval. The small black dotted line is consistent with the 90% confidence interval. The light grey line indicates the
Gaussian curve. Abbreviations: R = reaction time (a), K = clotting time (b), Alpha = alpha angle (c), MA =maximum amplitude (d), LY30 = lysis at
30 min (e), CI = coagulation index (f), G = clot rigidity (g)
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seen on the velocity curve by reduced TMRTG and
MRTG values.
The R value reflects the time from sample placement
in the cuvette until an amplitude of 2 mm is reached on
the TEG tracing. It is dependent on plasma clotting
factors and circulating inhibitor activity and represents
the initial fibrin formation rate [1]. The K value is a
measurement from the point where 2 mm of amplitude
is reached (R time) to the point of 20 mm amplitude.
This time reflects the buildup and cross linking of fibrin,
which is related to clotting factors such as factor II and
VII, fibrinogen and platelets count and function [1].
Furthermore, alpha and delta show a non-significant
trend towards hypercoagulability at 60 min. Alpha (°) is
the angle formed by the TEG tracing between the R and
the K value and reflects the speed of clot formation [1].
As alpha and MRTG reflect a similar item, a similarly
significant change could have been expected between
Fig. 4 Histograms showing the distribution of untransformed data for calculation of reference intervals of the novel TEG variables SP, delta,
TMRTG, MRTG, TMRL and MRL respectively. Data for measurement included the first results of all samples after 60 min of storage time. The solid
grey line represents the upper and the lower limit of the reference interval. The small black dotted line is consistent with the 90% confidence
interval. The light grey line indicates the Gaussian curve. Abbreviations: SP = split point (a), D = delta (b), TMRTG = time to maximum rate of
thrombus generation (c), MRTG =maximum rate of thrombus generation (d), TG = thrombus generation (e), TMRL = time to maximum rate of lysis
(f), MRL =maximum rate of lysis (g)
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the time points. However, alpha was not significantly
altered while MRTG was significantly affected by differ-
ent storage times. A possible explanation for this
discrepancy could be their different mode of change
during the coagulation process as described previously
for humans [7]: compared to alpha which is variable of
the traditional curve and shows a non-exponential
behavior, MRTG as a parameter derived from the
Fig. 5 Effect of citrate storage time (30 min versus 60 min) on the traditional thrombelastographic (TEG) variables expressed as box and whisker
diagrams. The central box represents values from the lower (25th) to upper (75th) percentile, while the middle line is consistent with the median.
The horizontal line depicts the minimum and maximum values. The level of significance was set at P < 0.05. Abbreviations: R = reaction time (a),
alpha degree (b), K = coagulation time (c), MA =maximum amplitude (d), G = clot rigidity (e), LY30 = lysis at 30 min (f), CI = coagulation index (g)
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Fig. 6 Effect of citrate storage time (30 min versus 60 min) on the novel thrombelastographic (TEG) variables expressed as box and whisker
diagrams. The central box represents values from the lower (25th) to upper (75th) percentile, while the middle line is consistent with the median.
The horizontal line depicts the minimum and maximum values. The level of significance was set at P < 0.05. Abbreviations: SP = split point (a), D
= delta (b), TMRTG = time to maximum rate of thrombus generation (c), MRTG =maximum rate of thrombus generation (d), TG = thrombus
generation (e), TMRL = time to maximum rate of lysis (f), MRL =maximum rate of lysis (g)
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velocity curve changes in an exponential and thus mark-
edly pronounced way.
A similar effect was noticed here for TMRTG which in
previous studies in human medicine has shown a linear
correlation with delta [6] so that theoretically a similar im-
pact of storage on both variables would have been
expected. However, the citrate storage time only had a sig-
nificant impact on the VC parameter TMRTG increasing
exponentially but not on delta derived from the traditional
TEG curve changing in a non-exponential mode. In
conclusion, some VC variables (TMRTG, MRTG) might
be a more sensitive marker of changes in coagulation
activity like hypercoagulability than traditional TEG
values. This hypothesis however, further has to be sub-
stantiated in future clinical studies.
A previous investigation in critically ill patients could
further demonstrate a linear relationship between delta
and TMRTG reflecting thrombin generation [6]. In our
study evaluating the impact of citrate storage time in
TEG variables, the behavior of TMRTG resembled the
findings observed for R more closely than those
observed for delta. It thus could be hypothesized, that
there is an even closer relationship between TMRTG
and R than there is between TMRTG and delta. Reasons
contributing to this difference in the current study
compared to Gonzalez et al. [6] might be the different
species, the different storage time, the different mode of
activation and the prophylactic therapy with heparin
potentially influencing the values as R partially depends
on the activity of circulating inhibitors [1]. Further
studies are needed to evaluate the relationship amongst
this threesome (TMRTG, R and delta).
Regarding TG, previously investigated in humans as
a marker of thrombin generation [4], the absolute
amount of thrombus generated (TG) in our study in
cats was interestingly not altered by prolonged citrate
storage times. In conjunction with the changes in
TMRTG and MRTG, citrate storage time apparently
rather affects the speed of clot formation and throm-
bin generation (as TMRTG is believed to be a marker
of thrombin generation [6]) than the total amount of
thrombin generated.
In agreement with our findings in cats, significant
differences with a tendency towards hypercoagulability
with longer storage time have been observed in dogs
[3] and horses [17]. In contrast to that, another study
in horses reported sample (citrated whole blood) sta-
bility at room temperature for up to 20 h prior to
TEG measurement, however, measurements were
made after 2 and 19 to 48 h of citrate storage time
so that changes prior 2 h of storage might have been
missed [18].
Despite from an incomplete inhibition of thrombin
formation during storage [3], repeated sampling from
a single tube could function as a “contact activator”
for the coagulation cascade via the pipette surface
which in humans has been shown to alter TEG
Fig. 7 Exemplarily illustration of the effect of citrate storage on the
conventional thrombelastographic (TEG) tracing and the velocity curve
(solid grey curve) in one cat included in the study. a: Analysis after
30 min, b: Analysis after 60 min. Note the shortening of the R-value
and the K-value as well as the increase of MRTG and shortening of
TMRTG consistent with a “hypercoagulable” TEG after increased
incubation time. Abbreviations: TMRTG = time to maximum rate of
thrombus generation, SP = split point, MRTG =maximum rate of
thrombus generation.
Table 4 Comparison of the velocity curve reference intervals
based on the maximum amplitude or clot rigidity
MA version G version
Variable (unit) RI Variable (unit) RI
TMRTG (min) 3.5–22.0 TMRTGG (min) 4.1–23.0
MRTG (mm/min) 4.0–19.3 MRTGG (dsc) 2.1–11.9
TG (mm/min) 255.3–751.2 TGG (dsc) 138.8–828.5
TMRL (min) 0.4–55.8 TMRLG (min) 0.0–55.9
MRL (mm/min) 0.0–4.7 MRLG (dsc) −1.6 – 7.7
For each variable, in both versions the same statistical method was used. G
version variables show an appended “G”
Abbreviations: MA maximum amplitude, G clot rigidity, RI reference interval,
TMRTG(G) time to maximum rate of thrombus generation, MRTG(G) maximum
rate of thrombus generation, TG(G) (total) thrombus generation, TMRL(G) time
to maximum rate of lysis, MRL(G) maximum rate of lysis, min minute, mm
millimeter, dsc dyn/cm2/s
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results [16]. The factor of repeated sampling has not
been determined in our study but in other veterinary
studies which used separate tubes for different time
points to avoid repeated pipetting and still showed
significant differences with a tendency towards hyper-
coagulability [3, 17]. Hypercoagulable TEG tracings
with prolonged storage times might thus be resulting
from different in vitro blood stability of different
mammalian species [17].
Conclusion
Storage of citrated whole blood used for TEG analysis in
cats has significant effects on both traditional and VC
variables with a trend towards hypercoagulability with
prolonged storage times. By that, some velocity curve
variables (explicitly TMRTG, MRTG) might help in the
early detection of changes in coagulation activity for
example hypercoagulable states.
Because of the effect of citrate storage times on TEG
analysis, RIs can only be used for a specific storage time
which has to be established in each laboratory.
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